AU2002360112A1 - Method for preparing an interactive compound of an anilide derivative with a porous support by supercritical fluid - Google Patents
Method for preparing an interactive compound of an anilide derivative with a porous support by supercritical fluidInfo
- Publication number
- AU2002360112A1 AU2002360112A1 AU2002360112A AU2002360112A AU2002360112A1 AU 2002360112 A1 AU2002360112 A1 AU 2002360112A1 AU 2002360112 A AU2002360112 A AU 2002360112A AU 2002360112 A AU2002360112 A AU 2002360112A AU 2002360112 A1 AU2002360112 A1 AU 2002360112A1
- Authority
- AU
- Australia
- Prior art keywords
- preparing
- supercritical fluid
- porous support
- anilide derivative
- interactive compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0113179A FR2830761B1 (en) | 2001-10-12 | 2001-10-12 | PROCESS FOR THE PREPARATION OF AN INTERACTIVE COMPOUND OF AN ANILIDE DERIVATIVE WITH A POROUS SUPPORT BY SUPERCRITICAL FLUID |
FR01/13179 | 2001-10-12 | ||
PCT/FR2002/003475 WO2003030867A2 (en) | 2001-10-12 | 2002-10-11 | Method for preparing an interactive compound of an anilide derivative with a porous support by supercritical fluid |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002360112A1 true AU2002360112A1 (en) | 2003-04-22 |
Family
ID=8868229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002360112A Abandoned AU2002360112A1 (en) | 2001-10-12 | 2002-10-11 | Method for preparing an interactive compound of an anilide derivative with a porous support by supercritical fluid |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002360112A1 (en) |
FR (1) | FR2830761B1 (en) |
WO (1) | WO2003030867A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2854079B1 (en) * | 2003-04-25 | 2007-11-30 | Pf Medicament | PROCESS FOR THE PREPARATION OF MOLECULAR COMPLEXES |
FR2876911B1 (en) * | 2004-10-21 | 2007-04-13 | Pierre Fabre Medicament Sa | COMPLEX COMPRISING PIROXICAM, CYCLODEXTRIN AND ARGININE |
PL2260871T3 (en) | 2004-04-01 | 2013-10-31 | Pf Medicament | Inclusion complexes comprising piroxicam, a cyclodextrin and arginine |
FR2876910B1 (en) | 2004-10-21 | 2007-04-13 | Pierre Fabre Medicament Sa | COMPLEX COMPRISING MEQUITAZINE, CYCLODEXTRIN AND INTERACTION AGENT |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2741619B1 (en) * | 1995-11-28 | 1998-02-13 | Pf Medicament | NOVEL 2,3,5-TRIMETHYL-4-HYDROXY-ANILIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
FR2803538B1 (en) * | 1999-12-15 | 2002-06-07 | Separex Sa | METHOD AND DEVICE FOR CAPTURING FINE PARTICLES BY PERCOLATION IN A BED OF GRANULES |
-
2001
- 2001-10-12 FR FR0113179A patent/FR2830761B1/en not_active Expired - Fee Related
-
2002
- 2002-10-11 WO PCT/FR2002/003475 patent/WO2003030867A2/en not_active Application Discontinuation
- 2002-10-11 AU AU2002360112A patent/AU2002360112A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003030867A3 (en) | 2003-12-04 |
FR2830761B1 (en) | 2003-12-12 |
FR2830761A1 (en) | 2003-04-18 |
WO2003030867A2 (en) | 2003-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1223474B8 (en) | Method for producing ester wax | |
AU2001252588A1 (en) | Method for preparing microsphere | |
AU2002333693A1 (en) | Method for producing micro-electromechanical components | |
IS7153A (en) | A process for the preparation of a 14-hydroxynormorphinone derivative | |
AU2002360112A1 (en) | Method for preparing an interactive compound of an anilide derivative with a porous support by supercritical fluid | |
EP1298117A3 (en) | Method for preparing bromofluorenes | |
AU2002315322A1 (en) | Method for the production of an aqueous acrylamide solution with a bio-catalyst | |
AU2001237734A1 (en) | Method of preparing alkaloids using supercritical fluids from plants | |
AU2001244100A1 (en) | Method for the optical analysis of a fluid | |
AU1316401A (en) | Method for the production of sorbents for chromatography | |
AU2001287723A1 (en) | Method for producing delta 1-pyrrolines | |
AU2001283791A1 (en) | Method for production of a support element for an ic component | |
AU2002352014A1 (en) | Method for the production of organodiphosphonites | |
AU2002351926A1 (en) | Method for the chromatographic isolation of ectoine | |
AU4652101A (en) | Method for the biotechnological production of l-alaninol | |
AU2002302700A1 (en) | Method for production of azo compounds | |
AU2002334739A1 (en) | Method of fabricating a support structure | |
AU2002358612A1 (en) | Method for the production of dihydroxycarboxylate esters | |
AU2002353630A1 (en) | A method for preparing of chiral 2,2-dimethylcyclopropanecarboxyl derivatives | |
AU2002317921A1 (en) | Method for preparing oestrogen derivatives | |
AU2002314062A1 (en) | Method for producing triazolyl methyl oxiranes | |
AU2002304325A1 (en) | Method of providing a dynamic cellular cardiac support | |
AU2002253731A1 (en) | A method for the packing of a reel | |
AU2002325348A1 (en) | Method for supporting dynamic password | |
AU2002338971A1 (en) | Method for the production of biperiden ii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |